By CHRISTABEL LIGAMI, TEA Special Correspondent
In Summary
- African cattle infected with the lethal parasite that kills one million cows per year are less likely to die when co-infected with the parasite’s milder cousin, according to the study.
- The findings suggest that “fighting fire with fire” is a strategy that could work against a range of parasitic diseases.
- The immediate implications are for the battle in Africa against a tick-borne cattle parasite, Theileria parva, which causes East Coast fever.
Research into the cattle killer disease East
Coast fever has found a protective process that may also work in human
malaria infections.
The study, published in Science Advances, suggests
that seeking a simple vaccine that could protect cows from East Coast
fever by inoculating them with a related but far less harmful parasite
may protect them against severe disease.
A similar process may work in malaria, where
infection with the less harmful Plasmodium vivax parasite may protect
humans from the Plasmodium falciparum parasite. The parasites cause
malaria, which kills more than 600,000 people around the world each
year.
African cattle infected with the lethal parasite
that kills one million cows per year are less likely to die when
co-infected with the parasite’s milder cousin, according to the study.
The findings suggest that “fighting fire with fire” is a strategy that could work against a range of parasitic diseases.
The immediate implications are for the battle in
Africa against a tick-borne cattle parasite, Theileria parva, which
causes East Coast fever. The disease kills one cow every 30 seconds and
causes $300 million in livestock losses each year, mostly for poor
herders.
The worst hit countries in Africa are Kenya,
Uganda, Rwanda, Tanzania and Burundi, DR Congo, Malawi, Mozambique,
South Sudan, Zambia and Zimbabwe.
The study, “Co-infections determine patterns of
mortality in a population exposed to parasite infections,” was conducted
as part of an Infectious Diseases of East African Livestock (IDEAL)
project, a multi-partner study that includes the Nairobi-based
International Livestock Research Institute (ILRI).
The project followed more than 500 indigenous East
African shorthorn zebu calves in Western Kenya during their first year
of life.
The calves were routinely exposed to both the T
parva parasite and its less aggressive relatives such as Theileria
mutans. The researchers discovered that co-infection with a lesser
parasite was associated with an impressive 89 per cent reduction in
deaths from East Coast fever.
“This is an important finding; East Coast fever is
a major burden for millions of poor people in Africa whose existence
depends on healthy cattle,” said Phil Toye, a researcher at ILRI, which
is leading an international effort to develop a new vaccine against the
disease.
“The available control methods are very expensive
for most farmers and herders, and if we could provide a cheaper
approach, it could greatly reduce poverty in the region.”
The current first-generation vaccine being used by
farmers is credited with saving 620,000 cows and a formulation released
in 2012 has been in high demand. However, the vaccine costs $8 to $12
per animal, which is steep for many pastoralists and smallholder
farmers.
Also limiting its wider adoption are its strict
refrigeration requirements and its production difficulties, as it takes
18 months to make a single batch of the vaccine.
The ILRI researchers are now developing an East
Coast fever jab that stimulates the production of antibodies to protect
against an infection and also stimulates the cow’s immune system to use
its own “natural killer T-cells” to attack white blood cells infected by
the parasite.
No comments:
Post a Comment